Presentation TCT 2022 Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial Presenter: Christos Rammos September 17, 2022
Presentation TCT 2022 TCT 235: 5-year prognostic value of QFR-guided revascularization in patients with stable coronary artery disease. A multicenter registry Presenter: Carlos Cortes September 17, 2022
Presentation TCT 2022 TCT 233: Investigation of the Utility of Angiography-Based Fractional Flow Reserve (FFRangio) in Comparison to Wire-Based Coronary Fractional Flow Reserve (FFR) in the Determination of Treatment Planning and Clinical Prognosis in Patients with Coronary… Presenter: Alejandro Froimovich September 17, 2022
Presentation TCT 2022 TCT 13: Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI Presenter: Alessandro Spirito September 17, 2022
Presentation TCT 2022 Case-Based Presentation: Sex-Specific Considerations of Physiologic Assessment of CAD in the Cath Lab Presenter: Rasha Al-Lamee September 17, 2022
Presentation TCT 2022 Case-Based Presentation: Is There a Role of Intravascular Imaging in the Diagnosis of SCAD? Presenter: Jacqueline Saw September 17, 2022
Presentation TCT 2022 Case-Based Presentation: MINOCA – Current Evidence on Prognosis and Treatment Presenter: Jacqueline Tamis-Holland September 17, 2022
Presentation TCT 2022 Keynote Speech: Diagnosis and Treatment of CAD in Women – The Role of Social Determinant of Health Presenter: Clyde Yancy September 17, 2022
Presentation TCT 2022 INOCA: Noninvasive vs Invasive Diagnostic Approach – FFR, CFR, IMR Presenter: Jennifer Tremmel September 17, 2022
Presentation TCT 2022 Management of Coronary Artery Disease in CLTI? Is That the Ticket? Presenter: Christopher Zarins September 17, 2022
Presentation TCT 2022 TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease. Presenter: Marta Konopko September 17, 2022
Presentation TCT 2022 TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial Presenter: Zardasht Oqab September 17, 2022
Presentation TCT 2022 Case #1: Multivessel Coronary Artery Disease Presenter: Aakriti Gupta September 17, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
Presentation TCT 2021 BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease Presenter: IN-HO CHAE November 06, 2021
Presentation TCT 2021 BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease Presenter: Eline Ploumen November 06, 2021
Presentation TCT 2021 BIO-RISE CHINA: A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease Presenter: Yaling Han November 06, 2021
Presentation TCT 2021 TCT 101: Long-term Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Treating In-stent Restenosis in Unprotected Left Main Coronary Artery: Multicenter LM-DRAGON Registry Presenter: Wojciech Wojakowski November 05, 2021
News Conference News TCT 2021 Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM Michael O'Riordan November 04, 2021